Fraud and Abuse in the Sales and Marketing of Drugs and Medical Devices

October 17, 2002 - October 18, 2002
Tavern on the Green
New York, NY
The government's unprecedented crackdown on alleged fraud and abuse in the pharmaceutical industry — including criminal indictments of companies and individuals, hundreds of millions of dollars in fines and penalties, and multi-year corporate integrity agreements — has been a loud wake-up call for the industry regarding its sales and marketing activities. This crackdown has also startled the medical device industry which is now, too, under increased scrutiny for alleged fraudulent and abusive practices in its sales and marketing activities.

With every passing quarter, additional pharmaceutical manufacturers are disclosing in SEC filings that they are under civil and/or criminal investigation. The medical device industry also stands in the shadow of investigation. This comes as no surprise as the Justice Department, HHS Office of Inspector General, and FBI have all identified fraud and abuse in the pharmaceutical and medical device industries as one of their top enforcement priorities. As corporate counsel, sales and marketing executive, or compliance officer, you need an in-depth and up-to-the minute understanding of which practices could trigger an investigation or prosecution by the government — and what controls your company can put in place to manage risk in this dynamic environment of regulatory enforcement.

This American Conference Institute event will arm you with the vital knowledge necessary to prevent fraud and abuse in the sales and marketing practices of your company and to implement an effective compliance program. Valli F. Baldassano, Associate General Counsel and Senior Director of Global Compliance at Pharmacia, John T. Bentivoglio of Arnold & Porter, Kathleen A. Knight, Vice President and Co-General Counsel at Alcon and Lynn Shapiro Snyder of Epstein, Becker and Green will lead an outstanding faculty of top in-house counsel, compliance executives, key consultants, leading attorneys and senior government enforcement officials. They will discuss:
  • The government's current investigations and priorities involving pharmaceutical sales and marketing practices.
  • Specific commercial practices that could trigger a whistleblower complaint or government investigation.
  • Predictions for the OIG compliance guidance for the pharmaceutical industry and how your company can implement an effective compliance program.
  • The impact of the new PhRMA Code of Conduct on pharmaceutical sales and marketing practices.
A highlight of this program will be a keynote address by Dr. Audiey Kao of the American Medical Association on the "AMA Clarification for Gifts to Physicians from Industry". There will also be a special roundtable of state and federal prosecutors, including John A. Guthrie, Ohio Attorney General's Office; Robert M. Hanna, U.S. Attorney's Office (Newark); Michael Loucks, U.S. Attorney's Office (Boston); Patrick J. O'Connell, Texas Attorney General's Office and Ellen Sternfield, Oregon DOJ, Medicaid Fraud Unit. In addition, there will be a special pre-conference optional one day event on Preventing Fraudulent and Abusive Practices in the Sales and Marketing of Medical Devices and When Seeking Medicare Coverage: Doing It Right.

This power-packed program will provide the most practical and comprehensive package you need to ensure your company does not get targeted by the government for fraud and abuse.

Take this opportunity to learn from those on the cutting edge of industry compliance and meet and network with your colleagues. Benefit from the written materials prepared by the speakers especially for this conference. Network with your colleagues. Register by calling 1-888-224-2480 or registering on-line at
Subscribe Link

Email Disclaimer